Cleared Traditional

K134029 - BELTER BLOOD PRESSURE METER

K134029 is the FDA 510(k) clearance for BELTER BLOOD PRESSURE METER by Shenzhen Belter Health Measurement and Analysis TE. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 206-day FDA review.

K134029 · Shenzhen Belter Health Measurement and Analysis TE · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2014
Decision
206d
Days
Class 2
Risk

K134029 is an FDA 510(k) clearance for the BELTER BLOOD PRESSURE METER. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Shenzhen Belter Health Measurement and Analysis TE (Shenzhen, Guangdong, CN). The FDA issued a Cleared decision on July 25, 2014 after a review of 206 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Shenzhen Belter Health Measurement and Analysis TE devices

Submission Details

510(k) Number K134029 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 31, 2013
Decision Date July 25, 2014
Days to Decision 206 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
81d slower than avg
Panel avg: 125d · This submission: 206d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 501
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K134029.
BP652N (HEM-6300-Z)
K142917 · Omron Healthcare, Inc. · Dec 2014
AMBULO 2400 AMBULATORY BLOOD PRESSURE MONITORING SYSTEM
K133989 · Mortara Instrument, Inc. · Nov 2014
MICROLIFE WRIST WATCH BLOOD PRESSURE MONITOR
K141083 · Microlife Intellectual Property GmbH · Aug 2014
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K140121 · Andon Health Co, Ltd. · Jul 2014
EV1000 CLINICAL PLATFORM WITH CLEARSIGHT TM FINGER CUFF OR CLEARSIGHT TM SYSTEM
K140312 · Edwards Lifesciences, LLC · Jun 2014
HEM-7320
K133383 · Omron Healthcare, Inc. · Mar 2014